【Metagen Therapeutics, Inc.】 Metagen Therapeutics and FRONTEO Launch Joint Research on Microbiome-Based Drug Discovery Using AI

2025.07.01

Metagen Therapeutics, Inc. and FRONTEO, Inc. have announced the launch of a joint research project focused on microbiome-based drug discovery, an area gaining increasing global attention.

The collaboration utilizes FRONTEO’s AI-driven drug discovery support platform, “Drug Discovery AI Factory,” to analyze the functions of gut microbiota and their associations with various diseases, aiming to advance the application of the microbiome in pharmaceutical development.

◆Click the link for more details
Metagen Therapeutics and FRONTEO Launch Joint Research on Microbiome-Based Drug Discovery Using AI